先天性心臟病患者術(shù)后護理課件_第1頁
先天性心臟病患者術(shù)后護理課件_第2頁
先天性心臟病患者術(shù)后護理課件_第3頁
先天性心臟病患者術(shù)后護理課件_第4頁
先天性心臟病患者術(shù)后護理課件_第5頁
已閱讀5頁，還剩61頁未讀， 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明：本文檔由用戶提供并上傳，收益歸屬內(nèi)容提供方，若內(nèi)容存在侵權(quán)，請進行舉報或認領(lǐng)

文檔簡介

PostoperativeCareinthePatientWithCongenitalHeartDiseaseUTHSCSAPediatricResidentCurriculumforthePICUPostoperativeCareinthePati1GeneralPrinciplesPatienthomeostasisEarly–decliningtrendsdonotcorrectthemselvesLate–timecanbeimportantdiagnostictool“Theenemyofgoodisbetter”GeneralPrinciplesPatienthome2SpecificApproachesCardiovascularprinciplesApproachtorespiratorymanagementPaincontrol/sedationMetabolic/electrolytesInfectionEffectsofsurgicalinterventionsontheseparametersNOPARAMETEREXISTSINISOLATIONSpecificApproachesCardiovascu3先天性心臟病患者術(shù)后護理課件4先天性心臟病患者術(shù)后護理課件5MaximizingOxygenDeliveryOXYGENDELIVERYOXYGENCONTENTCARDIACOUTPUTX=MaximizingOxygenDeliveryOXYG6O2Content= Saturation(O2Capacity)+(PaO2)0.003OxygenCapacity=Hgb(10)(1.34)So..HemoglobinandsaturationsaredeterminantsofO2deliveryMaximizingOxygenDelivery

CardiacOutputO2Content=MaximizingOxygen7GiddingSSetal1988y=-0.26(x)+38R=0.77S.E.E.=1.6MaximizingOxygenDelivery

CardiacOutputGiddingSSetal1988Maximizin8MaximizingOxygenDelivery

CardiacOutputStrokeVolumeContractilityDiastolicFillingAfterloadHeartratePhysiologicResponseNon-physiologicResponseSinusvs.junctionalvs.pacedventricularrhythmCardiacOutputStrokeVolumeHeartRate=XMaximizingOxygenDelivery

Car9MaximizingOxygenOxygenconsumptionDecreasingmetabolicdemandsSedation/paralysisThermoregulationMaximizingOxygenOxygenconsum10VentilatorStrategiesRespiratoryacidosis/hypercarbiaOxygenationPhysiologyofsingleventricle/shuntlesionsOxygendelivery!Atelectasis–15-20cc/kgtidalvolumes.PEEP,inspiratorytimesVentilatorStrategiesRespirato11VentilatorStrategies:

PulmonaryHypertensionSedation/neuromuscularblockadeHighFiO2–nolessthan60%FiO2MildrespiratoryalkalosispH7.50-7.60pCO2–30-35mmHgNitricOxideVentilatorStrategies:

Pulmona12VentilatorStrategies:

PulmonaryHypertensionThevisciouscycleofPHTNPrecipitatingEvent-Coldstress-Suctioning-AcidosisMetabolicAcidosisHypercapniaIncreasedPVRDecreasedPulmonaryBloodFlowDecreasedLVpreloadRVdysfunctionCentralVenousHypertensionHypoxemiaLowoutputIschemiaVentilatorStrategies:

Pulmon13PainControl/SedationStressresponseattenuationLimitedmyocardialreserve–decreasingmetabolicdemandsLabilepulmonaryhypertensionAnalgesia/anxiolysisPainControl/SedationStressre14PainControl/SedationOpioidsMSO4–Goldstandard:bettersedativeeffectsthansyntheticopioidsCardioactive–histaminereleaseandlimitsendogenouscatecholaminesFentanyl/sufentanylLesshistaminereleaseMorelipidsoluble–betterCNSpenetrationPainControl/SedationOpioids15PainControl/SedationSedativesChloralhydrateCanbemyocardialdepressantMetabolitesincludetrichloroethanolandtrichloroaceticacidBenzodiazepinesValium/Versed/AtivanPainControl/SedationSedatives16PainControl/SedationMusclerelaxantsDepolarizing–SuccinylcholineBradycardia(ACH)Non-depolarizingPancuronium–tachycardiaVecuronium–shorterdurationAtracurium“spontaneously”metabolizedHistaminereleasePainControl/SedationMusclere17PainControl/SedationOthers:Barbiturates–vasodilation,cardiacdepressionPropofol–myocardialdepression,metabolicacidosisKetamine–increasesSVREtomidate–NocardiovasculareffectsPainControl/SedationOthers:18FluidandElectrolytesEffectsofunderlyingcardiacdiseaseEffectsoftreatmentofthatdiseaseFluidandElectrolytesEffects19CardiopulmonaryBypass“Controlledshock”LossofpulsatilebloodflowCapillaryleakVasoconstrictionRenovasculareffectsRenin/angiotensinCytokinereleaseEndothelialdamageand“sheerinjury”CardiopulmonaryBypass“Control20CardiopulmonaryBypassStressResponseSIRSMicroembolicEventsRenalInsufficiencyFluidAdministrationHemorrhageCapillaryLeakSyndromeFeltes,1998LungFluidFiltration=[()-()]MicrovascularHydrostaticPressureMicrovascularOncoticPressureCardiopulmonaryBypassStressS21CirculatoryArrestHypothermicprotectionofbrainandothertissuesAccesstosurgicalrepairnotaccessiblebyCPBaloneFurtheractivationofSIRS/worsenedcapillaryleak.CirculatoryArrestHypothermic22FluidandElectrolytePrinciplesCrystalloidTotalbodyfluidoverloadMaintenancefluid=1500-1700cc/m2/dayFluidadvancement:POD0:50-75%ofmaintenancePOD1:75%ofmaintenanceIncreaseby10%eachdaythereafterFluidandElectrolytePrincipl23FluidandElectrolytePrinciplesFlushesandCardiotonicDripsRemember:FlushesandAntibiotics=VolumeUTHSCSAprotocoltominimizecrystalloid:StandardDripConcentration

Mixindextroseorsalinecontainingfluidtooptimizeserumglucose&electrolytesSedation:(Usedcurrentlyascarrierfordrips)MSO4 2cc/hr=0.1mg/kg/hrFentanyl 2cc/hr=3mcg(micrograms)/kg/hrCardiotonicmedications:Dopamine/Dobutamine 50mg/50ccEpi/Norepinephrine 0.5mg/50ccMilrinone 5mg/50ccNipride(Nitroprusside) 0.5mg/50ccNitroglycerin 50mg/50ccPGEI 500mcg/50cc

FluidandElectrolytePrincipl24FluidandElectrolytePrinciplesIntravascularvolumeexpansion/FluidchallengesColloid–osmoticallyactiveFFP5%albumin/25%albuminPRBC’sHCTadequate:5%albumin(HR,LAP,CVP)HCTinadequate:5-10cc/kgPRBCCoagulopathic:FFP/CryoprecipitateOngoinglosses:CTandPeritonealfrequently=5%albuminFluidandElectrolytePrincipl25MetabolicEffectsGlucoseNeonatesvs.children/adultsHyperglycemiaintheearlypost-opperiodMetabolicEffectsGlucose26MetabolicEffectsCalciumMyocardialrequirementsRhythmContractilityVascularresistanceNEVERUNDERESTIMATETHEPOWEROFCALCIUM!MetabolicEffectsCalcium27Calcium/inotropesSarcoplasmicReticulumcAMP-DependentPKCaCaCaCaCaPhosphodiesteraseAdenylateCyclaseRegulatoryGProteinNacAMPcAMPcAMPAlpha1Beta1DAGIP3MyofibrilNaKSRCalcium/inotropesSarcoplasmicc28MetabolicEffectsPotassiumMetabolicacidosisRhythmdisturbancesMetabolicEffectsPotassium29ThermalRegulationAsasigntowatch,andanitemtomanipulate…PerfusionJunctionalectopictachycardiaMetabolicdemandsOxygenconsumptionInfectionThermalRegulationAsasignto30InfectionRoutineanti-staphylococcaltreatmentInfectionRoutineanti-staphylo31EffectsofSurgicalInterventionsCardiopulmonaryBypassvs.Non-BypassFluidsandelectrolytesModifiedultrafiltrationTypesofanatomicdefectsOvercirculated–increasedbloodvolumespreoperativelyUndercirculated–reperfusionofareapreviouslyexperiencingmuchreducedflowvolumes.EffectsofSurgicalInterventi32SummaryOptimizeoxygendeliverybymanipulationofcardiacoutputandhemoglobinSedationandpaincontrolcanaidintherecoveryAppreciateeffectsofcardiopulmonarybypassandcirculatoryarrestonfluidandelectrolytemanagementTightcontrolofallparameterswithinthefirst12hours;afterthattime,patientsmaybebetterabletodeclaretrendsthatcanguideyourinterventions.SummaryOptimizeoxygendeliver33PostoperativeCareinthePatientWithCongenitalHeartDiseaseUTHSCSAPediatricResidentCurriculumforthePICUPostoperativeCareinthePati34GeneralPrinciplesPatienthomeostasisEarly–decliningtrendsdonotcorrectthemselvesLate–timecanbeimportantdiagnostictool“Theenemyofgoodisbetter”GeneralPrinciplesPatienthome35SpecificApproachesCardiovascularprinciplesApproachtorespiratorymanagementPaincontrol/sedationMetabolic/electrolytesInfectionEffectsofsurgicalinterventionsontheseparametersNOPARAMETEREXISTSINISOLATIONSpecificApproachesCardiovascu36先天性心臟病患者術(shù)后護理課件37先天性心臟病患者術(shù)后護理課件38MaximizingOxygenDeliveryOXYGENDELIVERYOXYGENCONTENTCARDIACOUTPUTX=MaximizingOxygenDeliveryOXYG39O2Content= Saturation(O2Capacity)+(PaO2)0.003OxygenCapacity=Hgb(10)(1.34)So..HemoglobinandsaturationsaredeterminantsofO2deliveryMaximizingOxygenDelivery

CardiacOutputO2Content=MaximizingOxygen40GiddingSSetal1988y=-0.26(x)+38R=0.77S.E.E.=1.6MaximizingOxygenDelivery

CardiacOutputGiddingSSetal1988Maximizin41MaximizingOxygenDelivery

CardiacOutputStrokeVolumeContractilityDiastolicFillingAfterloadHeartratePhysiologicResponseNon-physiologicResponseSinusvs.junctionalvs.pacedventricularrhythmCardiacOutputStrokeVolumeHeartRate=XMaximizingOxygenDelivery

Car42MaximizingOxygenOxygenconsumptionDecreasingmetabolicdemandsSedation/paralysisThermoregulationMaximizingOxygenOxygenconsum43VentilatorStrategiesRespiratoryacidosis/hypercarbiaOxygenationPhysiologyofsingleventricle/shuntlesionsOxygendelivery!Atelectasis–15-20cc/kgtidalvolumes.PEEP,inspiratorytimesVentilatorStrategiesRespirato44VentilatorStrategies:

PulmonaryHypertensionSedation/neuromuscularblockadeHighFiO2–nolessthan60%FiO2MildrespiratoryalkalosispH7.50-7.60pCO2–30-35mmHgNitricOxideVentilatorStrategies:

Pulmona45VentilatorStrategies:

PulmonaryHypertensionThevisciouscycleofPHTNPrecipitatingEvent-Coldstress-Suctioning-AcidosisMetabolicAcidosisHypercapniaIncreasedPVRDecreasedPulmonaryBloodFlowDecreasedLVpreloadRVdysfunctionCentralVenousHypertensionHypoxemiaLowoutputIschemiaVentilatorStrategies:

Pulmon46PainControl/SedationStressresponseattenuationLimitedmyocardialreserve–decreasingmetabolicdemandsLabilepulmonaryhypertensionAnalgesia/anxiolysisPainControl/SedationStressre47PainControl/SedationOpioidsMSO4–Goldstandard:bettersedativeeffectsthansyntheticopioidsCardioactive–histaminereleaseandlimitsendogenouscatecholaminesFentanyl/sufentanylLesshistaminereleaseMorelipidsoluble–betterCNSpenetrationPainControl/SedationOpioids48PainControl/SedationSedativesChloralhydrateCanbemyocardialdepressantMetabolitesincludetrichloroethanolandtrichloroaceticacidBenzodiazepinesValium/Versed/AtivanPainControl/SedationSedatives49PainControl/SedationMusclerelaxantsDepolarizing–SuccinylcholineBradycardia(ACH)Non-depolarizingPancuronium–tachycardiaVecuronium–shorterdurationAtracurium“spontaneously”metabolizedHistaminereleasePainControl/SedationMusclere50PainControl/SedationOthers:Barbiturates–vasodilation,cardiacdepressionPropofol–myocardialdepression,metabolicacidosisKetamine–increasesSVREtomidate–NocardiovasculareffectsPainControl/SedationOthers:51FluidandElectrolytesEffectsofunderlyingcardiacdiseaseEffectsoftreatmentofthatdiseaseFluidandElectrolytesEffects52CardiopulmonaryBypass“Controlledshock”LossofpulsatilebloodflowCapillaryleakVasoconstrictionRenovasculareffectsRenin/angiotensinCytokinereleaseEndothelialdamageand“sheerinjury”CardiopulmonaryBypass“Control53CardiopulmonaryBypassStressResponseSIRSMicroembolicEventsRenalInsufficiencyFluidAdministrationHemorrhageCapillaryLeakSyndromeFeltes,1998LungFluidFiltration=[()-()]MicrovascularHydrostaticPressureMicrovascularOncoticPressureCardiopulmonaryBypassStressS54CirculatoryArrestHypothermicprotectionofbrainandothertissuesAccesstosurgicalrepairnotaccessiblebyCPBaloneFurtheractivationofSIRS/worsenedcapillaryleak.CirculatoryArrestHypothermic55FluidandElectrolytePrinciplesCrystalloidTotalbodyfluidoverloadMaintenancefluid=1500-1700cc/m2/dayFluidadvancement:POD0:50-75%ofmaintenancePOD1:75%ofmaintenanceIncreaseby10%eachdaythereafterFluidandElectrolytePrincipl56FluidandElectrolytePrinciplesFlushesandCardiotonicDripsRemember:FlushesandAntibiotics=VolumeUTHSCSAprotocoltominimizecrystalloid:StandardDripConcentration

Mixindextroseorsalinecontainingfluidtooptimizeserumglucose&electrolytesSedation:(Usedcurrentlyascarrierfordrips)MSO4 2cc/hr=0.1mg/kg/hrFentanyl 2cc/hr=3mcg(micrograms)/kg/hrCardiotonicmedications:Dopamine/Dobutamine 50mg/50ccEpi/Norepinephrine 0.5mg/50ccMilrinone 5mg/50ccNipride(Nitroprusside) 0.5mg/50ccNitroglycerin 50mg/50ccPGEI 500mcg/50cc

FluidandElectrolytePrincipl57FluidandElectrolytePrinciplesIntravascularvolumeexpansion/FluidchallengesColloid–osmoticallyactiveFFP5%albumin/25%albuminPRBC’sHCTadequate:5%albumin(HR,LAP,CVP)HCTinadequate:5-10cc/kgPRBCCoagulopathic:FFP/CryoprecipitateOngoinglosses:CTandPeritonealfrequently=5%albuminFluidandElectrolytePrincipl58MetabolicEffectsGlucoseNeonatesvs.children/adultsHyperglycemiaintheearlypost-opperiodMetabolicEffectsGlucose59MetabolicEffectsCalciumMyocardialrequirementsRhy

溫馨提示

  • 1. 本站所有資源如無特殊說明，都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等，如果需要附件，請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙，網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽，若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間，僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理，對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯，并不能對任何下載內(nèi)容負責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當內(nèi)容，請與我們聯(lián)系，我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

最新文檔

評論

0/150

提交評論